Sabby Management
Latest statistics and disclosures from Sabby Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Spdr S&p 500 Etf Tr option, Spdr S&p 500 Etf Tr option, Ishares Tr option, Ishares Tr Index option, SPY, and represent 90.56% of Sabby Management's stock portfolio.
- Added to shares of these 10 stocks: Spdr S&p 500 Etf Tr option (+$21M), Spdr S&p 500 Etf Tr option (+$15M), Ishares Tr option (+$13M), Ishares Tr Index option, TOYO, SPY, FAMI, CRVO, Paranovus Entertnmnt Tech Lt, TPST.
- Started 10 new stock positions in TOYO, Smart Powerr Corp, SIDU, Nuwellis, BIAF, Paranovus Entertnmnt Tech Lt, Ishares Tr option, CRVO, Spdr S&p 500 Etf Tr option, FAMI.
- Reduced shares in these 10 stocks: Gevo, ALP, DSY, INM, TC, CPOP, MBRX, BCTXL, Biodexa Pharmaceuticals, RKDA.
- Sold out of its positions in BNBX, RKDA, BJDX, CANF, CLDI, Gevo, LYRA, Biodexa Pharmaceuticals, MBRX, TRX. TC, DSY, SXTC, CPOP, ALP.
- Sabby Management was a net buyer of stock by $59M.
- Sabby Management has $111M in assets under management (AUM), dropping by 145.21%.
- Central Index Key (CIK): 0001535610
Tip: Access up to 7 years of quarterly data
Positions held by Sabby Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sabby Management
Sabby Management holds 23 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| State Street Spdr S&p Etf Put Option | 49.0 | $54M | +62% | 725.00 | 74677.00 |
|
| State Street Spdr S&p Etf Call Option | 13.9 | $15M | NEW | 205.00 | 74677.00 |
|
| Ishares Russell Etf Call Option | 12.0 | $13M | NEW | 442.00 | 30045.00 |
|
| Ishares Russell Etf Put Option | 12.0 | $13M | +47% | 441.00 | 30045.00 |
|
| State Street Spdr S&p Etf (SPY) | 3.7 | $4.1M | +101% | 5.5k | 746.77 |
|
| Toyo Ord (TOYO) | 3.2 | $3.5M | NEW | 504k | 6.95 |
|
| Abivax Sa Ads Call Option | 1.0 | $1.1M | +6% | 82.00 | 13326.00 |
|
| Farmmi Cl A (FAMI) | 0.8 | $840k | NEW | 3.5M | 0.24 |
|
| Sidus Space Cl A Put Option | 0.7 | $816k | +176% | 2.9k | 281.00 |
|
| Cervomed (CRVO) | 0.7 | $772k | NEW | 249k | 3.10 |
|
| Kempharm Put Option | 0.6 | $612k | +25% | 427.00 | 1434.00 |
|
| Tempest Therapeutics (TPST) | 0.5 | $568k | +2763% | 511k | 1.11 |
|
| Paranovus Entertnmnt Tech Lt Cl A | 0.5 | $561k | NEW | 75k | 7.43 |
|
| Bioaffinity Technologies (BIAF) | 0.3 | $297k | NEW | 366k | 0.81 |
|
| Smart Powerr Corp | 0.2 | $263k | NEW | 128k | 2.06 |
|
| Briacell Therapeutics Corp (BCTX) | 0.2 | $262k | +9% | 81k | 3.24 |
|
| Revelation Biosciences (REVB) | 0.2 | $217k | +111% | 211k | 1.03 |
|
| Senestech (SNES) | 0.2 | $211k | -35% | 142k | 1.49 |
|
| Briacell Therapeutics Corp *W (BCTXL) | 0.2 | $169k | -49% | 190k | 0.89 |
|
| Sidus Space Cl A (SIDU) | 0.1 | $122k | NEW | 43k | 2.81 |
|
| Inmed Pharmaceuticals (INM) | 0.1 | $70k | -79% | 45k | 1.55 |
|
| Nuwellis | 0.0 | $50k | NEW | 16k | 3.05 |
|
| Briacell Therapeutics Corp *W (BCTXZ) | 0.0 | $12k | -41% | 121k | 0.09 |
|
Past Filings by Sabby Management
SEC 13F filings are viewable for Sabby Management going back to 2012
- Sabby Management 2026 Q2 filed Aug. 14, 2026
- Sabby Management 2026 Q1 filed May 15, 2026
- Sabby Management 2025 Q4 filed Feb. 17, 2026
- Sabby Management 2025 Q3 filed Nov. 14, 2025
- Sabby Management 2025 Q2 filed Aug. 14, 2025
- Sabby Management 2025 Q1 filed May 15, 2025
- Sabby Management 2024 Q4 filed Feb. 14, 2025
- Sabby Management 2024 Q3 filed Nov. 14, 2024
- Sabby Management 2024 Q2 filed Aug. 14, 2024
- Sabby Management 2024 Q1 filed May 15, 2024
- Sabby Management 2023 Q4 filed Feb. 14, 2024
- Sabby Management 2023 Q3 filed Nov. 14, 2023
- Sabby Management 2023 Q2 filed Aug. 14, 2023
- Sabby Management 2023 Q1 filed May 15, 2023
- Sabby Management 2022 Q4 filed Feb. 14, 2023
- Sabby Management 2022 Q3 filed Nov. 14, 2022